Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Matthew J. Armstrong, Piers Gaunt, Guruprasad P. Aithal, +13

The Lancet

Placebo-controlled Phase 2Liraglutide SafetyHepatologyNon-alcoholic SteatohepatitisHepatotoxicity +3

Early phase clinical trials extension to guidelines for the content of statistical analysis plans

Victoria Homer, Christina Yap, Simon Bond, +16

BMJ

New ItemsClinical EndpointClinical TrialsVarious StakeholdersRandomized Controlled Trial +14

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial

Matthew J. Armstrong, Darren Barton, Piers Gaunt, +8

BMJ Open

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial

Penella J. Woll, Piers Gaunt, Sarah Danson, +8

Lung Cancer

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial

Ava Lorenc, Mary Wells, Tessa Fulton‐Lieuw, +26

Clinical Oncology

UKMCC-01: A phase II study of pazopanib (PAZ) in metastatic Merkel cell carcinoma.

Paul Nathan, Piers Gaunt, Keith Wheatley, +17

Journal of Clinical Oncology

Cancer ManagementCancer PharmacologyPathologyPhase Ii StudyMetronomic Chemotherapy +16

Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).

Zeeshaan-ul Hasan, Ikhlaaq Ahmed, Rubeta Matin, +18

Discovery Research Portal (University of Dundee)

The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

Laura Forker, Piers Gaunt, Stefano Sioletic, +13

British Journal of Cancer

Feasibility of Dose-escalated Hypofractionated Chemoradiation in Human Papilloma Virus-negative or Smoking-associated Oropharyngeal Cancer

Susanna Meade, Piers Gaunt, A. Hartley, +8

Clinical Oncology

Cancer-associated VirusCervical CancerRadiation TherapyDose-escalated Hypofractionated ChemoradiationMedicine +8

P1.07-015 STOMP: A UK National Cancer Research Network Randomised, Double Blind, Multicentre Phase II Trial of Olaparib as Maintenance Therapy in SCLC

Penella J. Woll, Piers Gaunt, Nicola Steele, +9

Journal of Thoracic Oncology

OncologyP1.07-015 StompCancer ManagementClinical TrialsMaintenance Therapy +7